Even Belimumab, a recombinant human IgG-1λ monoclonal antibody that inhibits B-cell activating factor (BLyS/BAFF), effective in lupus nephritis (271), shown to occur, in its effectiveness, with the restoration of the Treg/Th17 balance (272). The gene discussed is TNFSF13B; the disease is lupus nephritis.